ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/07/29 | 1,700 | 1,709 | 1,674 | 1,708 | +37 | +2.2% | 320,100 |
2021/07/28 | 1,712 | 1,729 | 1,666 | 1,671 | -54 | -3.1% | 420,100 |
2021/07/27 | 1,770 | 1,770 | 1,714 | 1,725 | -32 | -1.8% | 350,500 |
2021/07/26 | 1,766 | 1,775 | 1,755 | 1,757 | +6 | +0.3% | 234,000 |
2021/07/21 | 1,747 | 1,770 | 1,732 | 1,751 | +39 | +2.3% | 441,700 |
2021/07/20 | 1,734 | 1,744 | 1,695 | 1,712 | -37 | -2.1% | 444,000 |
2021/07/19 | 1,738 | 1,768 | 1,727 | 1,749 | +12 | +0.7% | 328,400 |
2021/07/16 | 1,733 | 1,757 | 1,726 | 1,737 | +6 | +0.3% | 243,500 |
2021/07/15 | 1,792 | 1,793 | 1,729 | 1,731 | -45 | -2.5% | 374,200 |
2021/07/14 | 1,751 | 1,790 | 1,751 | 1,776 | +16 | +0.9% | 320,000 |
2021/07/13 | 1,736 | 1,772 | 1,736 | 1,760 | +9 | +0.5% | 357,700 |
2021/07/12 | 1,731 | 1,770 | 1,726 | 1,751 | +55 | +3.2% | 461,000 |
2021/07/09 | 1,690 | 1,728 | 1,671 | 1,696 | -20 | -1.2% | 840,700 |
2021/07/08 | 1,785 | 1,785 | 1,696 | 1,716 | -109 | -6% | 2,448,400 |
2021/07/07 | 1,810 | 1,837 | 1,796 | 1,825 | +7 | +0.4% | 403,300 |
2021/07/06 | 1,830 | 1,847 | 1,803 | 1,818 | -1 | -0.1% | 366,300 |
2021/07/05 | 1,870 | 1,872 | 1,818 | 1,819 | -38 | -2% | 452,800 |
2021/07/02 | 1,856 | 1,863 | 1,827 | 1,857 | ±0 | ±0% | 569,900 |
2021/07/01 | 1,820 | 1,872 | 1,797 | 1,857 | +28 | +1.5% | 733,300 |
2021/06/30 | 1,782 | 1,831 | 1,782 | 1,829 | +49 | +2.8% | 758,200 |
2021/06/29 | 1,726 | 1,796 | 1,726 | 1,780 | +25 | +1.4% | 506,400 |
2021/06/28 | 1,779 | 1,780 | 1,738 | 1,755 | -8 | -0.5% | 417,500 |
2021/06/25 | 1,750 | 1,767 | 1,743 | 1,763 | +10 | +0.6% | 376,800 |
2021/06/24 | 1,792 | 1,814 | 1,749 | 1,753 | +18 | +1% | 836,900 |
2021/06/23 | 1,735 | 1,757 | 1,731 | 1,735 | +4 | +0.2% | 370,800 |
2021/06/22 | 1,686 | 1,739 | 1,670 | 1,731 | +79 | +4.8% | 543,000 |
2021/06/21 | 1,670 | 1,684 | 1,639 | 1,652 | -52 | -3.1% | 502,600 |
2021/06/18 | 1,720 | 1,748 | 1,696 | 1,704 | -3 | -0.2% | 592,500 |
2021/06/17 | 1,695 | 1,714 | 1,677 | 1,707 | -3 | -0.2% | 412,800 |
2021/06/16 | 1,696 | 1,720 | 1,696 | 1,710 | -7 | -0.4% | 282,800 |
2021/06/15 | 1,648 | 1,724 | 1,647 | 1,717 | +84 | +5.1% | 602,100 |
2021/06/14 | 1,602 | 1,657 | 1,593 | 1,633 | -20 | -1.2% | 520,400 |
2021/06/11 | 1,643 | 1,655 | 1,628 | 1,653 | +19 | +1.2% | 417,700 |
2021/06/10 | 1,648 | 1,654 | 1,621 | 1,634 | -24 | -1.4% | 461,600 |
2021/06/09 | 1,607 | 1,674 | 1,606 | 1,658 | +56 | +3.5% | 568,100 |
2021/06/08 | 1,618 | 1,655 | 1,595 | 1,602 | +22 | +1.4% | 734,000 |
2021/06/07 | 1,571 | 1,587 | 1,554 | 1,580 | +18 | +1.2% | 246,500 |
2021/06/04 | 1,547 | 1,569 | 1,542 | 1,562 | +19 | +1.2% | 249,800 |
2021/06/03 | 1,549 | 1,554 | 1,529 | 1,543 | -5 | -0.3% | 362,200 |
2021/06/02 | 1,563 | 1,570 | 1,541 | 1,548 | -15 | -1% | 254,700 |
2021/06/01 | 1,575 | 1,575 | 1,550 | 1,563 | ±0 | ±0% | 205,900 |
2021/05/31 | 1,594 | 1,595 | 1,551 | 1,563 | -5 | -0.3% | 294,900 |
2021/05/28 | 1,554 | 1,577 | 1,554 | 1,568 | +31 | +2% | 275,200 |
2021/05/27 | 1,548 | 1,552 | 1,532 | 1,537 | -21 | -1.3% | 414,300 |
2021/05/26 | 1,560 | 1,564 | 1,549 | 1,558 | +9 | +0.6% | 233,400 |
2021/05/25 | 1,566 | 1,575 | 1,543 | 1,549 | +6 | +0.4% | 340,900 |
2021/05/24 | 1,559 | 1,599 | 1,539 | 1,543 | -56 | -3.5% | 563,900 |
2021/05/21 | 1,605 | 1,610 | 1,585 | 1,599 | +14 | +0.9% | 435,300 |
2021/05/20 | 1,625 | 1,630 | 1,570 | 1,585 | -7 | -0.4% | 722,400 |
2021/05/19 | 1,544 | 1,606 | 1,533 | 1,592 | +47 | +3% | 586,900 |
951~
1000
件表示中 / 5112件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 90,000円 | +20.3% | - | 0.00% | 159.57倍 | 1.19倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
ハートシード | 366,500円 | +174.2% | - | 0.00% | - | 11.00倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
栄研化 | 212,900円 | +4.1% | -3.1% | 2.72% | 18.54倍 | 1.62倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
JCRファーマ | 54,800円 | +14.3% | - | 3.65% | 22.26倍 | 1.42倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
あすかHD | 232,900円 | +16.9% | +33.2% | 2.36% | 12.70倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム